![Joseph Damasio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/01/2026
Joseph Luis Damasio is currently Chief Financial Officer at Harvard Apparatus Regenerative Technology, Inc. since 2022.
Formerly, Mr. Damasio was Finance Director at Nelipak Corp., Vice President-Finance & Administration at Pressure BioSciences, Inc. in 2012, Chief Financial Officer & VP-Finance at Pressure BioSciences, Inc. from 2017 to 2019, Senior Accountant at BearingPoint, Inc., Auditor at PricewaterhouseCoopers LLP, Controller at XL Hybrids, Inc. from 2019 to 2020, Vice President-Finance at Inhibikase Therapeutics, Inc. from 2021 to 2022, and Controller at Cue Biopharma, Inc. from 2020 to 2021.
Education includes an MBA from Boston College and an undergraduate degree from the University of Massachusetts.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 06/07/2012 | 20 ( -.--% ) | 0 $ | 31/01/2026 | |
| 21/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Director Financiero/CFO | 08/08/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director Financiero/CFO | 08/08/2022 |
| CUE BIOPHARMA, INC. | Comptroller/Controller/Auditor | 01/10/2021 |
XL Hybrids, Inc.
 XL Hybrids, Inc. Auto Parts: OEMProducer Manufacturing Develops hybrid electric powertrain technology for commercial and municipal fleets | Comptroller/Controller/Auditor | 01/06/2020 |
| PRESSURE BIOSCIENCES, INC. | Director Financiero/CFO | 22/02/2019 |
| PRESSURE BIOSCIENCES, INC. | Director Financiero/CFO | 08/08/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Pressure BioSciences, Inc.
 Pressure BioSciences, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes infectious disease diagnostic products | Health Technology |
BearingPoint, Inc.
 BearingPoint, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management and technology consulting services | Commercial Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
XL Hybrids, Inc.
XL Hybrids, Inc. Auto Parts: OEMProducer Manufacturing Develops hybrid electric powertrain technology for commercial and municipal fleets | Producer Manufacturing |
Harvard Apparatus Regenerative Technology, Inc.
 Harvard Apparatus Regenerative Technology, Inc. Medical SpecialtiesHealth Technology Engages in the development and commercialization of medical devices | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Nelipak Corp.
 Nelipak Corp. Miscellaneous Commercial ServicesCommercial Services Provides healthcare packaging solutions | Commercial Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
